Nanosynth Group Plc announced that Dr Gareth Cave, currently a Non-executive Director of the Company, has been appointed as an Executive Director and as the Group's Chief Scientific Officer. Dr Cave's intended change of role, which at that time was subject to contract, was announced on September 1, 2021. Dr Cave is a university chemistry lecturer and has spent his academic career researching many applications of nanotechnology, from drug delivery systems to plant food. Beyond academia, as an active consultant, he shares his knowledge and know-how across a plethora of industries including pharmaceutical, healthcare, materials, agricultural, food and drink industries. In 2015 he formed Pharm 2 Farm Ltd, a wholly owned subsidiary of nanosynth group plc, as a university spinout, to help realise the full commercial potential of this nanotechnology research.